Literature DB >> 2813793

High-grade malignancies of the parotid gland: identification with MR imaging.

P M Som1, H F Biller.   

Abstract

Most tumors in the parotid gland are either benign neoplasms or low-grade malignancies. The magnetic resonance (MR) images of 29 patients with such tumors were reviewed. These masses typically have low T1-weighted and high T2-weighted signal intensities and have clearly defined margins. The signal characteristics presumably reflect the serous and mucinous products that are characteristic of these lesions. The MR images of six patients with aggressive parotid tumors were reviewed and correlated with operative and pathologic findings. These high-grade parotid lesions are uncommon, usually have poorly defined margins, and have low T1- and T2-weighted signal intensities. These signal characteristics presumably reflect the lack of serous and mucinous products, the high mitotic ratio, and the high nuclear to cytoplasmic ratios that are characteristic of these lesions. The authors conclude that the findings of these tumors on MR images are characteristic and should be suggestive of their diagnosis. The preoperative diagnosis of these high-grade tumors allows a more radical surgical treatment to be well planned before surgery. The primary differential diagnoses of these aggressive tumors with MR imaging include fibrosis and sialolithiasis.

Entities:  

Mesh:

Year:  1989        PMID: 2813793     DOI: 10.1148/radiology.173.3.2813793

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  20 in total

1.  Unusual CT and MR findings of inflammatory pseudotumor in the parapharyngeal space: case report.

Authors:  K Nakayama; Y Inoue; T Aiba; K Kono; K Wakasa; R Yamada
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

2.  Different imaging techniques in the head and neck: Assets and drawbacks.

Authors:  Thomas J Vogl; Marc Harth; Petra Siebenhandl
Journal:  World J Radiol       Date:  2010-06-28

3.  Management of malignant parotid tumors.

Authors:  Nikolaos Papadogeorgakis; Lampros Goutzanis; Vassilis Petsinis; Constantinos Alexandridis
Journal:  Oral Maxillofac Surg       Date:  2011-01-05

4.  Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.

Authors:  Young Cheol Weon; Sun-Won Park; Hyung-Jin Kim; Han-Sin Jeong; Young-Hyeh Ko; In Suh Park; Sung Tae Kim; Chung Hwan Baek; Young-Ik Son
Journal:  Neuroradiology       Date:  2012-02-04       Impact factor: 2.804

5.  Diagnosing common parotid tumours with magnetic resonance imaging including diffusion-weighted imaging vs fine-needle aspiration cytology: a comparative study.

Authors:  H Yerli; E Aydin; N Haberal; A Harman; T Kaskati; S Alibek
Journal:  Dentomaxillofac Radiol       Date:  2010-09       Impact factor: 2.419

6.  Different histological subtypes of parotid gland tumors: CT findings and diagnostic strategy.

Authors:  Zhi-Feng Xu; Fang Yong; Tian Yu; Ying-Yu Chen; Qiang Gao; Tao Zhou; Ai-Zhen Pan; Ren-Hua Wu
Journal:  World J Radiol       Date:  2013-08-28

7.  Head and neck MRI of Kimura disease.

Authors:  T Horikoshi; K Motoori; T Ueda; R Shimofusa; T Hanazawa; Y Okamoto; H Ito
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

8.  The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.

Authors:  Ning Zheng; Rui Li; Wenjuan Liu; Shuo Shao; Shan Jiang
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

Review 9.  Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features.

Authors:  Hiroki Kato; Masaya Kawaguchi; Tomohiro Ando; Keisuke Mizuta; Mitsuhiro Aoki; Masayuki Matsuo
Journal:  Jpn J Radiol       Date:  2018-05-29       Impact factor: 2.374

10.  Preoperative diagnostic values of fine-needle cytology and MRI in parotid gland tumors.

Authors:  J Paris; F Facon; T Pascal; M A Chrestian; G Moulin; M Zanaret
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-15       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.